Form 10-Q · Quarterly report
Amphenol 10-Q, filed Jul 31, 2026
- Filed
- CIK
- 0000820313
- Accession no.
- 0001104659-26-089194
Summary
Amphenol filed its Form 10-Q for the three and six months ended June 30, 2026, reporting results across three segments — Communications Solutions, Harsh Environment Solutions, and Interconnect and Sensor Systems. The filing cites increased debt and interest expense risk tied to the CommScope acquisition and notes the OECD/G20 Pillar Two global minimum tax framework.
Key points
- Amphenol reports in three segments: Communications Solutions, Harsh Environment Solutions, and Interconnect and Sensor Systems.
- The filing flags increased debt and interest expense as a risk resulting from the CommScope acquisition.
- The company cites the OECD/G20 Inclusive Framework's Pillar Two global minimum tax guidance as relevant to its tax position.
- Financial figures are presented alongside non-GAAP measures including Constant Currency Net Sales Growth and Organic Net Sales Growth.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (amounts in millions, except share and per share data, unless otherwise noted) The following discussion and analysis of the financial condition and results of operations for the three and six months ended June 30, 2026 and 2025 has been derived from and should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes thereto included in Part I, Item 1 herein for Amphenol Corporation (together with its subsidiaries, “Amphenol,” the “Company,” “we,” “our” or “us”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.